Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

A single mutation in cyclodextrin glycosyltransferase from Paenibacillus barengoltzii changes cyclodextrin and maltooligosaccharides production.

Castillo J, Caminata Landriel S, Sánchez Costa M, Taboga OA, Berenguer J, Hidalgo A, Ferrarotti SA, Costa H.

Protein Eng Des Sel. 2018 Oct 1;31(10):399-407. doi: 10.1093/protein/gzy034.

PMID:
30690526
2.

The autographa californica multiple nucleopolyhedrovirus Ac12: A non-essential F box-like protein that interacts with cellular SKP1 component of the E3 ubiquitin ligase complex.

Costa Navarro GS, Amalfi S, López MG, Llauger G, Arneodo JD, Taboga O, Alfonso V.

Virus Res. 2019 Jan 15;260:67-77. doi: 10.1016/j.virusres.2018.11.010. Epub 2018 Nov 22.

PMID:
30472094
3.

Recombinant occlusion bodies of baculovirus as carriers of a non-structural protein of foot-and-mouth disease virus.

Diez M, Trotta M, Alfonso V, Taboga O, López MG.

3 Biotech. 2018 Nov;8(11):457. doi: 10.1007/s13205-018-1482-x. Epub 2018 Oct 20.

PMID:
30370198
4.

Baculovirus capsid display in vaccination schemes: effect of a previous immunity against the vector on the cytotoxic response to delivered antigens.

Molinari P, Molina GN, Tavarone E, Del Médico Zajac MP, Morón G, Taboga O.

Appl Microbiol Biotechnol. 2018 Dec;102(23):10139-10146. doi: 10.1007/s00253-018-9368-8. Epub 2018 Sep 20.

PMID:
30238142
5.

Biotechnological applications of occlusion bodies of Baculoviruses.

López MG, Diez M, Alfonso V, Taboga O.

Appl Microbiol Biotechnol. 2018 Aug;102(16):6765-6774. doi: 10.1007/s00253-018-9130-2. Epub 2018 Jun 5. Review.

PMID:
29872886
6.

Novel biotechnological platform based on baculovirus occlusion bodies carrying Babesia bovis small antigenic peptides for the design of a diagnostic enzyme-linked immunosorbent assay (ELISA).

López MG, Pallarés HM, Alfonso V, Carmona SJ, Farber M, Taboga O, Wilkowsky SE.

Appl Microbiol Biotechnol. 2018 Jan;102(2):885-896. doi: 10.1007/s00253-017-8662-1. Epub 2017 Nov 27.

PMID:
29177536
7.

Successful production of the potato antimicrobial peptide Snakin-1 in baculovirus-infected insect cells and development of specific antibodies.

Almasia NI, Molinari MP, Maroniche GA, Nahirñak V, Barrios Barón MP, Taboga OA, Vazquez Rovere C.

BMC Biotechnol. 2017 Nov 9;17(1):75. doi: 10.1186/s12896-017-0401-2.

8.

Comparison of internal process control viruses for detection of food and waterborne viruses.

Blanco Fernández MD, Barrios ME, Cammarata RV, Torres C, Taboga OA, Mbayed VA.

Appl Microbiol Biotechnol. 2017 May;101(10):4289-4298. doi: 10.1007/s00253-017-8244-2. Epub 2017 Mar 29.

PMID:
28357543
9.

Assessing Tn5 and Sleeping Beauty for transpositional transgenesis by cytoplasmic injection into bovine and ovine zygotes.

Bevacqua RJ, Fernandez-Martin R, Canel NG, Gibbons A, Texeira D, Lange F, Vans Landschoot G, Savy V, Briski O, Hiriart MI, Grueso E, Ivics Z, Taboga O, Kues WA, Ferraris S, Salamone DF.

PLoS One. 2017 Mar 16;12(3):e0174025. doi: 10.1371/journal.pone.0174025. eCollection 2017.

10.

The localization of a heterologous displayed antigen in the baculovirus-budded virion determines the type and strength of induced adaptive immune response.

Tavarone E, Molina GN, Amalfi S, Peralta A, Molinari P, Taboga O.

Appl Microbiol Biotechnol. 2017 May;101(10):4175-4184. doi: 10.1007/s00253-017-8183-y. Epub 2017 Feb 17.

PMID:
28213733
11.

Two Distinctive Phenotypes of AcMNPV Display Different Immune Abilities and Intracellular Destiny.

Molina GN, Tavarone E, Taboga O, Molinari P.

PLoS One. 2016 Dec 29;11(12):e0168939. doi: 10.1371/journal.pone.0168939. eCollection 2016.

12.

Effects of deletion of the ac109 gene of Autographa californica nucleopolyhedrovirus on interactions with mammalian cells.

Alfonso V, Amalfi S, López MG, Taboga O.

Arch Virol. 2017 Mar;162(3):835-840. doi: 10.1007/s00705-016-3142-y. Epub 2016 Nov 21.

PMID:
27868165
13.

Efficient edition of the bovine PRNP prion gene in somatic cells and IVF embryos using the CRISPR/Cas9 system.

Bevacqua RJ, Fernandez-Martín R, Savy V, Canel NG, Gismondi MI, Kues WA, Carlson DF, Fahrenkrug SC, Niemann H, Taboga OA, Ferraris S, Salamone DF.

Theriogenology. 2016 Nov;86(8):1886-1896.e1. doi: 10.1016/j.theriogenology.2016.06.010. Epub 2016 Jun 15.

PMID:
27566851
14.

Allelic differences in a vacuolar invertase affect Arabidopsis growth at early plant development.

Leskow CC, Kamenetzky L, Dominguez PG, Díaz Zirpolo JA, Obata T, Costa H, Martí M, Taboga O, Keurentjes J, Sulpice R, Ishihara H, Stitt M, Fernie AR, Carrari F.

J Exp Bot. 2016 Jul;67(14):4091-103. doi: 10.1093/jxb/erw185. Epub 2016 May 18.

PMID:
27194734
15.

Canarypox virus expressing infectious bursal disease VP2 protein as immunogen for chickens.

Zanetti FA, Grand MD, Mitarotonda RC, Taboga OA, Calamante G.

Braz J Microbiol. 2014 May 19;45(1):231-4. eCollection 2014.

16.

Artificial microRNAs as antiviral strategy to FMDV: structural implications of target selection.

Gismondi MI, Ortiz XP, Currá AP, Asurmendi S, Taboga O.

J Virol Methods. 2014 Apr;199:1-10. doi: 10.1016/j.jviromet.2013.12.016. Epub 2014 Jan 7.

PMID:
24406623
17.

Enhanced IRES activity by the 3'UTR element determines the virulence of FMDV isolates.

García-Nuñez S, Gismondi MI, König G, Berinstein A, Taboga O, Rieder E, Martínez-Salas E, Carrillo E.

Virology. 2014 Jan 5;448:303-13. doi: 10.1016/j.virol.2013.10.027. Epub 2013 Nov 9.

18.

Co-inoculation of baculovirus and FMDV vaccine in mice, elicits very early protection against foot and mouth disease virus without interfering with long lasting immunity.

Quattrocchi V, Molinari P, Langellotti C, Gnazzo V, Taboga O, Zamorano P.

Vaccine. 2013 May 31;31(24):2713-8. doi: 10.1016/j.vaccine.2013.03.067. Epub 2013 Apr 12.

PMID:
23588086
19.

VP1 protein of Foot-and-mouth disease virus (FMDV) impairs baculovirus surface display.

Peralta A, Maroniche GA, Alfonso V, Molinari P, Taboga O.

Virus Res. 2013 Jul;175(1):87-90. doi: 10.1016/j.virusres.2013.03.018. Epub 2013 Apr 6.

PMID:
23566950
20.

Functional analysis of Spodoptera frugiperda nucleopolyhedrovirus late expression factors in Sf9 cells.

Berretta MF, López MG, Taboga O, Sciocco-Cap A, Romanowski V.

Virus Genes. 2013 Feb;46(1):152-61. doi: 10.1007/s11262-012-0843-5. Epub 2012 Nov 4.

PMID:
23124597
21.

AcMNPV core gene ac109 is required for budded virion transport to the nucleus and for occlusion of viral progeny.

Alfonso V, Maroniche GA, Reca SR, López MG, del Vas M, Taboga O.

PLoS One. 2012;7(9):e46146. doi: 10.1371/journal.pone.0046146. Epub 2012 Sep 26.

22.

[Development and preliminary assessment of a recombinant canarypox virus as an antirabic vaccine candidate].

Zanetti F, Rudak L, Micucci M, Grand DC, Luque A, Russo S, Taboga O, Pérez O, Calamante G.

Rev Argent Microbiol. 2012 Apr-Jun;44(2):75-84. Spanish.

PMID:
22997764
23.
24.

In vivo subcellular localization of Mal de Río Cuarto virus (MRCV) non-structural proteins in insect cells reveals their putative functions.

Maroniche GA, Mongelli VC, Llauger G, Alfonso V, Taboga O, del Vas M.

Virology. 2012 Sep 1;430(2):81-9. doi: 10.1016/j.virol.2012.04.016. Epub 2012 May 18.

25.

Detection and kinetic analysis of Epinotia aporema granulovirus in its lepidopteran host by real-time PCR.

Arneodo JD, König GA, Berretta MF, Di Rienzo JA, Taboga O, Sciocco-Cap A.

Arch Virol. 2012 Jun;157(6):1149-53. doi: 10.1007/s00705-012-1265-3. Epub 2012 Mar 8.

PMID:
22398913
26.

Development of a novel set of Gateway-compatible vectors for live imaging in insect cells.

Maroniche GA, Mongelli VC, Alfonso V, Llauger G, Taboga O, del Vas M.

Insect Mol Biol. 2011 Oct;20(5):675-85. doi: 10.1111/j.1365-2583.2011.01100.x.

PMID:
22093064
27.

Baculovirus capsid display potentiates OVA cytotoxic and innate immune responses.

Molinari P, Crespo MI, Gravisaco MJ, Taboga O, Morón G.

PLoS One. 2011;6(8):e24108. doi: 10.1371/journal.pone.0024108. Epub 2011 Aug 30.

28.

Surface display of AcMNPV occlusion-derived P74 does not enhance oral infectivity of budded viruses.

Alfonso V, López MG, Carrillo E, Taboga O.

Intervirology. 2012;55(3):247-51. doi: 10.1159/000324538. Epub 2011 May 17.

29.

Description of a novel single mutation in the AcMNPV polyhedrin gene that results in abnormally large cubic polyhedra.

López MG, Alfonso V, Carrillo E, Taboga O.

Arch Virol. 2011 Apr;156(4):695-9. doi: 10.1007/s00705-010-0885-8. Epub 2010 Dec 19.

PMID:
21170727
30.

Functional and biochemical properties of Mal de Río Cuarto virus (Fijivirus, Reoviridae) P9-1 viroplasm protein show further similarities to animal reovirus counterparts.

Maroniche GA, Mongelli VC, Peralta AV, Distéfano AJ, Llauger G, Taboga OA, Hopp EH, del Vas M.

Virus Res. 2010 Sep;152(1-2):96-103. doi: 10.1016/j.virusres.2010.06.010. Epub 2010 Jun 22.

PMID:
20600394
31.

Baculovirus treatment fully protects mice against a lethal challenge of FMDV.

Molinari P, García-Nuñez S, Gravisaco MJ, Carrillo E, Berinstein A, Taboga O.

Antiviral Res. 2010 Aug;87(2):276-9. doi: 10.1016/j.antiviral.2010.05.008. Epub 2010 May 24.

PMID:
20580746
32.

Trans-complementation of polyhedrin by a stably transformed Sf9 insect cell line allows occ- baculovirus occlusion and larval per os infectivity.

López MG, Alfonso V, Carrillo E, Taboga O.

J Biotechnol. 2010 Jan 15;145(2):199-205. doi: 10.1016/j.jbiotec.2009.10.015. Epub 2009 Nov 5.

PMID:
19896510
33.

Chimeric recombinant rotavirus-like particles as a vehicle for the display of heterologous epitopes.

Peralta A, Molinari P, Taboga O.

Virol J. 2009 Nov 6;6:192. doi: 10.1186/1743-422X-6-192.

34.

Potential use of the hemagglutinin-neuraminidase glycoprotein of Newcastle disease virus expressed in Rachiplusia nu larvae as an immunogen for chickens.

Chimeno Zoth S, Gómez E, Carballeda JM, Taboga O, Carrillo E, Berinstein A.

Clin Vaccine Immunol. 2009 May;16(5):775-8. doi: 10.1128/CVI.00432-08. Epub 2009 Mar 18.

35.

Production of rotavirus-like particles in Spodoptera frugiperda larvae.

Molinari P, Peralta A, Taboga O.

J Virol Methods. 2008 Feb;147(2):364-7. Epub 2007 Oct 22.

PMID:
17945356
36.
37.
38.

A chimeric baculovirus displaying bovine herpesvirus-1 (BHV-1) glycoprotein D on its surface and their immunological properties.

Peralta A, Molinari P, Conte-Grand D, Calamante G, Taboga O.

Appl Microbiol Biotechnol. 2007 May;75(2):407-14. Epub 2007 Feb 7.

PMID:
17285288
39.

[Recombinant baculovirus as immunogens].

Peralta A, Molinari MP, Taboga O.

Rev Argent Microbiol. 2006 Apr-Jun;38(2):74. Spanish. No abstract available.

PMID:
17037253
40.

Multiple recombinant ELISA for the detection of bovine viral diarrhoea virus antibodies in cattle sera.

Chimeno Zoth S, Taboga O.

J Virol Methods. 2006 Dec;138(1-2):99-108. Epub 2006 Sep 8.

PMID:
16963129
41.

Molecular characterization and phylogenetic analysis of Newcastle disease virus isolates from healthy wild birds.

Zanetti F, Berinstein A, Pereda A, Taboga O, Carrillo E.

Avian Dis. 2005 Dec;49(4):546-50.

PMID:
16404997
42.

Transgene expression enhancement in T-lymphoma cell lines.

Ruybal P, Gravisaco MJ, Barcala V, Escalada A, Cremaschi G, Taboga O, Waldner C, Mongini C.

Int Immunopharmacol. 2005 Nov;5(12):1685-92.

PMID:
16102518
43.

Mucosal and systemic immunization elicited by Newcastle disease virus (NDV) transgenic plants as antigens.

Berinstein A, Vazquez-Rovere C, Asurmendi S, Gómez E, Zanetti F, Zabal O, Tozzini A, Conte Grand D, Taboga O, Calamante G, Barrios H, Hopp E, Carrillo E.

Vaccine. 2005 Dec 1;23(48-49):5583-9. Epub 2005 Jul 28.

PMID:
16099555
44.
45.

High-level expression of recombinant 3AB1 non-structural protein from FMDV in insect larvae.

López MG, Peralta A, Berinstein A, Fondevila N, Carrillo E, Taboga O.

J Virol Methods. 2005 Mar;124(1-2):221-4. Epub 2004 Dec 13.

PMID:
15664073
46.

Immunological properties of FMDV-gP64 fusion proteins expressed on SF9 cell and baculovirus surfaces.

Tami C, Peralta A, Barbieri R, Berinstein A, Carrillo E, Taboga O.

Vaccine. 2004 Dec 21;23(6):840-5.

PMID:
15542209
47.

The knockout of the lprG-Rv1410 operon produces strong attenuation of Mycobacterium tuberculosis.

Bigi F, Gioffré A, Klepp L, Santangelo MP, Alito A, Caimi K, Meikle V, Zumárraga M, Taboga O, Romano MI, Cataldi A.

Microbes Infect. 2004 Feb;6(2):182-7.

PMID:
14998516
48.

Bovine herpes virus gD protein produced in plants using a recombinant tobacco mosaic virus (TMV) vector possesses authentic antigenicity.

Pérez Filgueira DM, Zamorano PI, Domínguez MG, Taboga O, Del Médico Zajac MP, Puntel M, Romera SA, Morris TJ, Borca MV, Sadir AM.

Vaccine. 2003 Oct 1;21(27-30):4201-9.

PMID:
14505899
49.

Evidence of the coevolution of antigenicity and host cell tropism of foot-and-mouth disease virus in vivo.

Tami C, Taboga O, Berinstein A, Núñez JI, Palma EL, Domingo E, Sobrino F, Carrillo E.

J Virol. 2003 Jan;77(2):1219-26.

50.

BHV-1 DNA vaccination: effect of the adjuvant RN-205 on the modulation of the immune response in mice.

Zamorano P, Taboga O, Domínguez M, Romera A, Puntel M, Tami C, Mongini C, Waldner C, Palma E, Sadir A.

Vaccine. 2002 Jun 21;20(21-22):2656-64.

PMID:
12034090

Supplemental Content

Loading ...
Support Center